Mer­ck pulls the plug on a study eval­u­at­ing block­buster Keytru­da with Yer­voy for NSCLC

About a month ago, up­on tout­ing new on­col­o­gy da­ta, Mer­ck reaf­firmed its com­mit­ment to ex­plor­ing new Keytru­da com­bi­na­tions for lung can­cer pa­tients. The Big …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.